Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Deposition Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet®) in Lung Transplant Recipients (Radiotagging Protocol)

NCT00235651 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00235651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00235651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Deposition Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet®) in Lung Transplant Recipients (Radiotagging Protocol)
Lead sponsor
University of Pittsburgh
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2005
Completion date
April 30, 2006
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung diseases, lung transplantation